-transparent.png){kind=logo}
Because novel SARS-CoV-2 variants continue to emerge, immunogenicity of XBB.1.5 monovalent vaccines against live clinical isolates needs to be evaluated. We report boosting of IgG (2.1×), IgA (1.5×), and total IgG/A/M (1.7×) targeting the spike receptor-binding domain and neutralizing titers against WA1 (2.2×), XBB.1.5 (7.4×), EG.5.1 (10.5×), and JN.1 (4.7×) variants.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Xammy Huu Nguyenla, and
Timothy A Bates, and
Mila Trank-Greene, and
Mastura Wahedi, and
Fikadu G Tafesse, and
Marcel E Curlin
January 2024,
Frontiers in immunology,
Xammy Huu Nguyenla, and
Timothy A Bates, and
Mila Trank-Greene, and
Mastura Wahedi, and
Fikadu G Tafesse, and
Marcel E Curlin
March 2024,
The Lancet. Infectious diseases,
Xammy Huu Nguyenla, and
Timothy A Bates, and
Mila Trank-Greene, and
Mastura Wahedi, and
Fikadu G Tafesse, and
Marcel E Curlin
June 2025,
Vaccine,
Xammy Huu Nguyenla, and
Timothy A Bates, and
Mila Trank-Greene, and
Mastura Wahedi, and
Fikadu G Tafesse, and
Marcel E Curlin
December 2024,
Vaccine,
Xammy Huu Nguyenla, and
Timothy A Bates, and
Mila Trank-Greene, and
Mastura Wahedi, and
Fikadu G Tafesse, and
Marcel E Curlin
December 2025,
Infectious diseases now,
Xammy Huu Nguyenla, and
Timothy A Bates, and
Mila Trank-Greene, and
Mastura Wahedi, and
Fikadu G Tafesse, and
Marcel E Curlin
September 2024,
Vaccine,
Xammy Huu Nguyenla, and
Timothy A Bates, and
Mila Trank-Greene, and
Mastura Wahedi, and
Fikadu G Tafesse, and
Marcel E Curlin
May 2024,
The Journal of infection,
Xammy Huu Nguyenla, and
Timothy A Bates, and
Mila Trank-Greene, and
Mastura Wahedi, and
Fikadu G Tafesse, and
Marcel E Curlin
July 2025,
Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi,
Xammy Huu Nguyenla, and
Timothy A Bates, and
Mila Trank-Greene, and
Mastura Wahedi, and
Fikadu G Tafesse, and
Marcel E Curlin
March 2024,
Cell host & microbe,
Xammy Huu Nguyenla, and
Timothy A Bates, and
Mila Trank-Greene, and
Mastura Wahedi, and
Fikadu G Tafesse, and
Marcel E Curlin
December 2023,
The Journal of allergy and clinical immunology,
